학술논문

Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?
Document Type
Article
Source
In: Expert Review of Pharmacoeconomics and Outcomes Research. (Expert Review of Pharmacoeconomics and Outcomes Research, 2023, 23(2):231-239)
Subject
Language
English
ISSN
17448379
14737167